A simple reversal of the way a long-standing surgical procedure is performed to create an arteriovenous fistula for hemodialysis access significantly improves the fistula's function and longevity over ...
San Francisco, CA—Early clinical data suggests that in situ catheter-based fistulas may be superior to surgical arteriovenous fistulas (AVFs) with respect to patency, need for re-intervention, and ...
TEMPE, Ariz.--(BUSINESS WIRE)--Tempe-based interventional nephrologists Randy Cooper, MD and Umar Waheed, MD, and their team at SKI Vascular Center, this week became the first ambulatory surgical ...
SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc., a company dedicated to developing and commercializing its breakthrough AlucentNVS technology for the treatment of vascular disease, announced ...
WALTHAM, Mass., Jan. 4, 2013 /PRNewswire/ -- Proteon Therapeutics, Inc., a private biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of ...
San Juan Capistrano, Calif. -- A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection ...